多药物诱导的血清素综合征揭示了潜在的神经认知障碍和宫骨髓病变
Jainam Shah1,2, Andrew Parsons3,2, Sachin Pathuri3,2
1Albert Einstein College of Medicine, Bronx, New York, USA jainam.shah@einsteinmed.edu.
BMJ case reports
|September 25, 2025
概括
血清激素综合征是一种严重的疾病,可以掩盖其他神经问题在老年人由于多药. 在复杂的老年病例中,仔细的药物检查对于准确的诊断和治疗至关重要.
科学领域:
- 老年医学 老年医学
- 临床神经学 临床神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血清激素综合征是一种潜在的致命性疾病,具有神经肌肉过度活动,自主性失调和精神状态的改变.
- 在患有并发病的老年患者中,多种药物增加了血清激素综合征的风险.
- 准确的诊断可能具有挑战性,因为症状与其他神经疾病重叠.
研究的目的:
- 报告一种血清激素综合征的病例,最初掩盖了老年人的潜在神经病理.
- 强调综合药物审查和复杂老年病例的多学科评估的重要性.
主要方法:
- 一个50多岁的女性患有多种并发病 (糖尿病,高血压,慢性病) 的病例报告.
- 详细审查她的药物治疗方案,包括超治疗性帕洛克塞丁,阿里皮普拉和热素.
- 诊断工作包括宫脊椎MRI,脑部成像和对治疗的反应 (cyproheptadine,haloperidol).
主要成果:
- 患者出现了暗示血清激素综合征的症状,这种症状在停止服用血清激素药物和cyproheptadine后得到改善.
- 持续的运动缺陷导致进一步调查,揭示了C4-C5圆盘突起与带压缩和大脑缩.
- 谨慎地服用哈洛佩里多尔并没有加剧症状,这表明药物诱导或结构性帕金森症.
结论:
- 不协调的药物治疗和过早的诊断关闭在老年患者中构成重大风险.
- 血清激素综合征可以掩盖潜在的神经疾病,需要彻底的药物审查和多学科评估.
- 在老年护理中,与多药相关的不良药物事件的早期识别和管理至关重要.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
639
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
639
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
896
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
896
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K


